$21.1 Million is the total value of DC Funds, LP's 2 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
VACC | New | VACCITECH PLCads | $10,776,000 | – | 642,204 | +100.0% | 51.19% | – |
HOWL | New | WEREWOLF THERAPEUTICS INC | $10,274,000 | – | 589,102 | +100.0% | 48.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2021-08-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VACCITECH PLC | 10 | Q3 2023 | 51.2% |
WEREWOLF THERAPEUTICS INC | 10 | Q3 2023 | 48.8% |
TSCAN THERAPEUTICS INC | 9 | Q3 2023 | 33.5% |
View DC Funds, LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-14 |
13F-HR | 2024-02-13 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-10 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-12 |
13F-HR | 2022-05-13 |
13F-HR | 2022-02-11 |
View DC Funds, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.